When paired with moderate exercise, results amplify, with some achieving 15-25 pounds lost over three months
Retrieved from Canadian Agency for Drugs and Technologies in Health
Semaglutide (marketed under the brand name Wegovy) and liraglutide (Saxenda) did lead to weight loss, but it was significantly less at 15% and 8%, respectively
No unpredictable handling windows
GLP-1 (Glucagon-Like Peptide-1) as distributed by Peptides Lab UK is not intended for, and must not be used for, human consumption, medical treatment, self-administration, veterinary applications, or any use outside of a controlled laboratory environment
The site is a longstanding, government-run database of human clinical trials that are being run worldwide